NEUROIMAGING AND CSF BIOMARKER PROGRAM

NEUROIMAGING AND CSF BIOMARKER PROGRAM

Up to $600,000 based on stage and scope of research.Only direct costs are allowed. - Monday, September 14, 2026 (LOI)

Alzheimer's Drug Discovery Foundation
The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias.

Funding Opportunity

Visit the funding page (members only, sign in): NEUROIMAGING AND CSF BIOMARKER PROGRAM

Sign in or register for free to read the full details and apply

Sign in Create a free account

Share:

All funding opportunities